Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

1994 • 2,614 citations

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

1990 • 1,310 citations

Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients

1988 • 893 citations

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1994 • 852 citations

A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease

1992 • 738 citations

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

1988 • 662 citations

Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture

1994 • 575 citations

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.

1990 • 432 citations

Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.

1994 • 424 citations

Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile

1992 • 359 citations

Lesion morphology and coronary angioplasty: Current experience and analysis

1992 • 268 citations

Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplasty

1989 • 152 citations

Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen Activators

1997 • 152 citations

Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

1997 • 118 citations

Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery.

1983 • 118 citations

Angioscopic versus angiographic detection of initial detection of intimal dissection and intracoronary thrombus

1994 • 106 citations

Restenosis after successful percutaneous transluminal coronary angioplasty

1990 • 81 citations

Does Intracoronary Thrombus Influence the Outcome of High Risk Percutaneous Transluminal Coronary Angioplasty? Clinical and Angiographic Outcomes in a Large Multicenter Trial fn1fn1This study was suppported by a grant from Centocor, Inc.

1998 • 61 citations

Changing incidence and management of abrupt closure following coronary intervention in the new device era

1992 • 58 citations

Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplasty

1993 • 30 citations

Coronary lesions at increased risk

1995 • 23 citations

Complementarity of stenting and abciximab for percutaneous coronary intervention

1998 • 8 citations

Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.

1996 • 8 citations

Complementarity of Stenting and Abciximab for Percutaneous Coronary Intervention

1998 • 6 citations

934-23 Reproducibility of Qualitative and Quantitative Angiographic Findings in the New Approaches to Coronary Intervention (NACI) Registry

1995 • 3 citations